Anna Delvey is being a “pain” with constant complaints about her ankle monitor, according to sources — but the “Fake Heiress” told The Post it’s not about style, she just doesn’t ...
GSK is closing down a facility and is winding down antibiotic manufacturing operations at another factory as Novartis’ Sandoz ...
Anna Sorokin’s parents have long maintained a low profile despite their daughter’s infamy Nicole Briese is a contributing writer at PEOPLE. She has been working at PEOPLE since 2022. Her work ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...
After an initial defeat against the biggest barrier to mRNA flu vaccines—namely, B strains of influenza—GSK has returned with a reformulated candidate that has delivered the goods in the all ...
GSK has turned to Brooke Shields to get the message out about shingles vaccination. The drugmaker has worked with the model and actor to talk to female celebrities and patients aged 50 years and ...
GSK has shifted towards a global marketing model influenced by a Netflix-style approach that aims to match content to the person receiving it. Richard Staines heard about this new strategy at the ...
Without your help, we wouldn't be able to fight for truth and justice. Hosts of The View have read a statement from Anna Delvey’s lawyer after claiming she still owes her victims money.
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. The company's product portfolio includes prescription medicines and ...
GSK Says mRNA Flu Shot Shows Promise in Boost for Pipeline GSK could beat Pfizer to market, says chief commercial officer Several drugmakers are betting on mRNA seasonal flu vaccines ...
On July 31, GSK released its financial results for the second quarter of 2024, which again beat analysts' expectations by a wide margin. Under Emma Walmsley's leadership, the company is becoming a ...
GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...